Hormone Therapy Compromised Breast Cancer Diagnosis Via Mammogram And Biopsy

[flashl]

A new US study found that women taking combined hormone therapy had an increased risk of otherwise avoidable abnormal mammograms and breast biopsies that compromised the ability of these two methods to help diagnose breast cancer.

The study was carried out by lead author Dr Rowan T Chlebowski, an investigator at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), and colleagues, and is published in the 25th February issue of the Archives of Internal Medicine.

In a press statement Chlebowski said that the findings "represent a concern for post-menopausal women who are considering hormone therapy".

The effect of combined hormone therapy on the detection of breast cancer has not been determined before, wrote the researchers in their background information to the article.

Medical News Today